Emerging Treatments for Subarachnoid Hemorrhage

Matthew C Findlay,Mrinmoy Kundu,Jayson R Nelson,Kyril L Cole,Candace Winterton,Samuel Tenhoeve,Brandon Lucke-Wold,Matthew C. Findlay,Jayson R. Nelson,Kyril L. Cole
DOI: https://doi.org/10.2174/0118715273279212240130065713
2024-02-22
CNS & Neurological Disorders - Drug Targets
Abstract:Abstract: The current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic advancements, patient-specific treatment plans can be individualized and optimized to deliver outstanding care for the best possible SAH-related outcomes.
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?